133 related articles for article (PubMed ID: 31206033)
61. miR-15/107 microRNA Gene Group: Characteristics and Functional Implications in Cancer.
Turco C; Donzelli S; Fontemaggi G
Front Cell Dev Biol; 2020; 8():427. PubMed ID: 32626702
[TBL] [Abstract][Full Text] [Related]
62. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.
Liang Y; Song X; Li Y; Chen B; Zhao W; Wang L; Zhang H; Liu Y; Han D; Zhang N; Ma T; Wang Y; Ye F; Luo D; Li X; Yang Q
Mol Cancer; 2020 May; 19(1):85. PubMed ID: 32384893
[TBL] [Abstract][Full Text] [Related]
63. m
Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
[TBL] [Abstract][Full Text] [Related]
64. miR-107 targets TRIAP1 to regulate oral squamous cell carcinoma proliferation and migration.
Na C; Li X; Zhang J; Han L; Li Y; Zhang H
Int J Clin Exp Pathol; 2019; 12(5):1820-1825. PubMed ID: 31934005
[TBL] [Abstract][Full Text] [Related]
65. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
Li X; Li M; Zhao T; Zhang J
Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
[TBL] [Abstract][Full Text] [Related]
66. High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
Liu Y; Cao Y; Yang X; Chen H; Yang H; Liu Y; Gu W
Transl Cancer Res; 2023 Apr; 12(4):913-927. PubMed ID: 37180663
[TBL] [Abstract][Full Text] [Related]
67. Long noncoding RNA FTX promotes epithelial-mesenchymal transition of epithelial ovarian cancer through modulating miR-7515/TPD52 and activating Met/Akt/mTOR.
Li Y; Zhu X; Zhang C; Yin Y; Chen L; Liu Y; He A; Xia F
Histol Histopathol; 2023 Dec; 38(12):1487-1498. PubMed ID: 37140169
[TBL] [Abstract][Full Text] [Related]
68. Effects of miR-107 on Breast Cancer Cell Growth and Death via Regulation of the PTEN/AKT Signaling Pathway.
Pan H; Peng H; Dai Y; Han B; Yang G; Jiang N; Zhou P
J Oncol; 2023; 2023():1244067. PubMed ID: 36816358
[TBL] [Abstract][Full Text] [Related]
69. Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth.
Chen Y; Gong W; Zhou Y; Fan R; Wu Y; Pei W; Sun S; Xu X; Jiang H
Transl Cancer Res; 2020 Apr; 9(4):2941-2950. PubMed ID: 35117650
[TBL] [Abstract][Full Text] [Related]
70.
Jiang F; Lv Q; Hu C; Li Z; Wu H; Gao S; Wang H; Zhao Y; Shao Q
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885209
[TBL] [Abstract][Full Text] [Related]
71. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
Jiang L; Zhang Y; Guo L; Liu C; Wang P; Ren W
BMC Cancer; 2021 Dec; 21(1):1290. PubMed ID: 34856955
[TBL] [Abstract][Full Text] [Related]
72. Contribution of miRNAs in the Pathogenesis of Breast Cancer.
Ghafouri-Fard S; Khanbabapour Sasi A; Abak A; Shoorei H; Khoshkar A; Taheri M
Front Oncol; 2021; 11():768949. PubMed ID: 34804971
[TBL] [Abstract][Full Text] [Related]
73. MicroRNAs as a clue to overcome breast cancer treatment resistance.
Garrido-Cano I; Pattanayak B; Adam-Artigues A; Lameirinhas A; Torres-Ruiz S; Tormo E; Cervera R; Eroles P
Cancer Metastasis Rev; 2022 Mar; 41(1):77-105. PubMed ID: 34524579
[TBL] [Abstract][Full Text] [Related]
74. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells.
Chen HA; Li CC; Lin YJ; Wang TF; Chen MC; Su YH; Yeh YL; Padma VV; Liao PH; Huang CY
Aging (Albany NY); 2021 Apr; 13(8):12046-12057. PubMed ID: 33901009
[TBL] [Abstract][Full Text] [Related]
75. Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis.
Liu G; Zhang Z; Song Q; Guo Y; Bao P; Shui H
Onco Targets Ther; 2020; 13():9497-9511. PubMed ID: 33061434
[TBL] [Abstract][Full Text] [Related]
76. Targeting micro-RNAs by natural products: a novel future therapeutic strategy to combat cancer.
Alnuqaydan AM
Am J Transl Res; 2020; 12(7):3531-3556. PubMed ID: 32774718
[TBL] [Abstract][Full Text] [Related]
77. Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer.
Wong JS; Cheah YK
Noncoding RNA; 2020 Jul; 6(3):. PubMed ID: 32668603
[TBL] [Abstract][Full Text] [Related]
78. miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel.
Wang G; Ma C; Shi X; Guo W; Niu J
Open Med (Wars); 2019; 14():456-466. PubMed ID: 31206033
[TBL] [Abstract][Full Text] [Related]
79. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
Liu YY; Zhang LY; Du WZ
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
[TBL] [Abstract][Full Text] [Related]
80. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
